Meet The Speakers

2022 Expert-Speaker Faculty

Agnete Fredriksen

Chief Innovation & Strategy Officer

Nykode Therapeutics

Andrea Coluccio

Senior Scientist Translational Medicine

Medigene

Andrew Allen

CEO

Gritstone bio

Aude-Helene Capietto

Senior Principal Scientific Researcher, Cancer Immunology

Genentech

David Gfeller

Associate Professor

University of Lausanne

Elisa Scarselli

Chief Scientific Officer

Nouscom Srl

Eric Halioua

President & CEO

PDC*line Pharma

Erik Wiklund

Chief Executive Officer

Targovax ASA

Florian Kast

Postdoctoral Researcher

Roche

Guido Leoni

Head of Bioinformatics

Nouscom Srl

Heinrich Haas

Vice President Formulation and Drug Development

BioNTech AG

Heinz Lubenau

Chief Executive Officer & Co-Founder

Vaximm GmbH

Hugh Salter

Chief Scientific Officer

Anocca AB

Jean-Marc Limacher

Co-Founder, President & Chief Medical Officer

Odimma therapeutics

Jeffrey Bockman

Executive Vice President of Commercial BioConsulting & Head of Oncology

Lumanity

Jens Kringelum

Jens Kringelum

Director, Genomic Immuno-Oncology

Evaxion Biotech

Jeroen van Bergen

Chief Scientific Officer

Immunetune

Jessica Matta

Co-Founder & Chief Executive Officer & Chief Scientific Officer

Odimma therapeutics

Julie Rumble

Manager of Immunology Contract Services

Cayman Chemical

Juliet Frederiksen

Head of Disease Systems Biology and Biomarker Discovery

Intomics

Kaidre Bendjama

Kaidre Bendjama

Project Leader - Personalised Cancer Vaccines

Transgene

Kostas

Kostas Kosmatopoulos

CEO

Vaxon Biotech

Maik Pruess

Maik Pruess

Senior Field Applications Scientist

Personalis

Matthew Davies

Head Of Bioinformatics

Enara Bio

Maximilian Bosch

Project Manager

Lung Center, Cantonal Hospital St.Gallen, Switzerland

Morten Nielsen

Professor Department of Health Technology

The Technical University of Denmark

Muna Abdullahi

Research Analyst

Beacon Targeted Therapies

Nicola Ternette

Principle Investigator, Antigen Discovery

University of Oxford

Peter Joyce

Chief Executive Officer & Co-founder

Grey Wolf Therapeutics Ltd.

Peter Sondermann

CEO

Tacalyx GmbH

Philip Arlen

Philip Arlen

President & Chief Executive Officer

Precision BioLogic

Thomas Sandal

CTO R&D

PokeAcell

Sari Pesonen

Co-Founder & Chief Scientific Officer

Valo Therapeutics

Sijme Zeilemaker

Chief Executive Officer

Immunetune

Sine Hadrup

Chief Scientific Officer

pokeAcell

Stephane Depil

Onco-Hematology Specialist Immuno-Oncology & Cancer Immunotherapy

Centre Leon Berard

Trevor Clancy

Chief Scientific Officer

NEC OncoImmunity

Victor Levitsky

Chief Scientific Officer

Targovax

Wigard Kloosterman

Chief Scientific Officer Frame

Frame Therapeutics